Format

Send to

Choose Destination
Urol Clin North Am. 2014 May;41(2):257-66. doi: 10.1016/j.ucl.2014.01.008. Epub 2014 Feb 28.

Decision making and prostate cancer screening.

Author information

1
Health Services Research and Development Service, Office of Research and Development, Veterans Health Administration, 810 Vermont Avenue, Northwest, Washington, DC 20420, USA; Department of Psychiatry, University of California San Francisco, 401 Parnassus Avenue, San Francisco, CA 94143, USA; Department of Urology, University of California San Francisco, 400 Parnassus Avenue, Suite A610, San Francisco, CA 94123, USA. Electronic address: sara.knight@va.gov.

Abstract

This article presents an overview of the challenges that men encounter in making decisions about prostate cancer screening, including complex affective and cognitive factors and controversies in the interpretation of the evidence on prostate cancer screening. Shared decision making involving patient decision aids are discussed as approaches that can be used to improve the quality of prostate cancer screening decisions, including a close alignment between a man's values, goals, and preferences and his choice about screening.

KEYWORDS:

Informed decision making; Patient decision aid; Patient preferences; Patient values; Prostate cancer screening; Prostate specific antigen (PSA) test; Shared decision making; Values clarification

PMID:
24725488
DOI:
10.1016/j.ucl.2014.01.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center